UNITED THERAPEUTICS CORP (UTHR)

US91307C1027 - Common Stock

359.58  -0.58 (-0.16%)

After market: 359.58 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
1.686B
13.63%
1.936B
14.88%
2.328B
20.20%
2.94B
26.32%
3.252B
10.61%
3.463B
6.49%
3.729B
7.68%
3.886B
4.21%
4.088B
5.20%
4.36B
6.65%
3.965B
-9.06%
EBITDA
YoY % growth
738.4M
14.75%
1.042B
41.14%
1.242B
19.14%
1.511B
21.69%
1.627B
7.68%
1.642B
0.92%
1.466B
-10.72%
1.265B
-13.71%
1.131B
-10.59%
1.079B
-4.60%
1.044B
-3.24%
EBIT
YoY % growth
688.5M
15.99%
990.9M
43.92%
1.189B
19.94%
1.425B
19.90%
1.663B
16.70%
1.694B
1.86%
1.893B
11.75%
2.008B
6.08%
2.085B
3.83%
2.289B
9.78%
1.755B
-23.33%
Operating Margin
40.85%51.17%51.06%48.47%51.14%48.92%50.76%51.67%51.00%52.50%44.26%
EPS
YoY % growth
10.03
-13.39%
15.02
49.75%
19.84
32.09%
24.98
25.92%
28.43
13.78%
28.48
0.21%
32.07
12.57%
36.88
15.02%
39.14
6.11%
44.36
13.34%
16.02
-63.88%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
6.67
53.06%
7.23
17.21%
7.74
32.32%
8.00
25.24%
7.85
17.65%
8.40
16.18%
8.17
5.53%
8.04
0.47%
7.42
-5.44%
Revenue
Q2Q % growth
754.73M
22.78%
772.57M
14.00%
816.07M
14.15%
848.09M
13.24%
857.21M
13.58%
920.4M
19.13%
928.15M
13.73%
936.65M
10.44%
919.87M
7.31%
EBITDA
Q2Q % growth
401.15M
26.59%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
384.05M
45.64%
420.89M
18.13%
442.79M
38.42%
468.83M
14.85%
468.97M
22.11%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
6.39
18.77%
6.55-0.16-2.49%
Q2 2024
Q2Q % growth
5.85
11.64%
6.53-0.68-10.35%
Q1 2024
Q2Q % growth
6.17
26.95%
5.760.417.04%
Q4 2023
Q2Q % growth
4.36
63.30%
4.270.092.12%
Q3 2023
Q2Q % growth
5.38
9.57%
5.140.244.59%
Q2 2023
Q2Q % growth
5.24
117.43%
4.600.6414.02%
Q1 2023
Q2Q % growth
4.86
-3.38%
4.620.245.31%
Q4 2022
Q2Q % growth
2.67
13.62%
4.60-1.93-41.99%
Q3 2022
Q2Q % growth
4.91
43.57%
3.970.9423.61%
Q2 2022
Q2Q % growth
2.41
-33.97%
4.22-1.81-42.84%
Q1 2022
Q2Q % growth
5.03
724.59%
3.411.6247.41%
Q4 2021
Q2Q % growth
2.35
7.31%
3.79-1.44-38.00%
Q3 2021
Q2Q % growth
3.42
-11.40%
3.66-0.24-6.66%
Q2 2021
Q2Q % growth
3.65
51.45%
3.080.5718.49%
Q1 2021
Q2Q % growth
0.61
-80.45%
3.00-2.39-79.67%
Q4 2020
Q2Q % growth
2.19
82.50%
3.20-1.01-31.60%
Q3 2020
Q2Q % growth
3.86
22.15%
2.890.9733.66%
Q2 2020
Q2Q % growth
2.41
-41.36%
2.93-0.52-17.70%
Q1 2020
Q2Q % growth
3.12
11.03%
2.800.3211.23%
Q4 2019
Q2Q % growth
1.20
-18.92%
2.73-1.53-56.12%
Q3 2019
Q2Q % growth
3.16
30.58%
2.490.6726.97%
Q2 2019
Q2Q % growth
4.11
3.27%
2.541.5761.68%
Q1 2019
Q2Q % growth
2.81
-49.55%
2.83-0.02-0.79%
Q4 2018
Q2Q % growth
1.48 2.60-1.12-43.02%
Q3 2018
Q2Q % growth
2.42 3.32-0.90-27.09%
Q2 2018
Q2Q % growth
3.98 3.230.7523.09%
Q1 2018
Q2Q % growth
5.57 3.581.9955.41%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
748.9M
22.89%
737.03M11.87M1.61%
Q2 2024
Q2Q % growth
714.9M
19.85%
705.7M9.2M1.30%
Q1 2024
Q2Q % growth
677.7M
33.70%
636.44M41.26M6.48%
Q4 2023
Q2Q % growth
614.7M
25.07%
587.39M27.31M4.65%
Q3 2023
Q2Q % growth
609.4M
18.10%
598.84M10.56M1.76%
Q2 2023
Q2Q % growth
596.5M
27.76%
534.65M61.85M11.57%
Q1 2023
Q2Q % growth
506.9M
9.74%
524.66M-17.76M-3.39%
Q4 2022
Q2Q % growth
491.5M
18.38%
529.59M-38.09M-7.19%
Q3 2022
Q2Q % growth
516M
16.03%
503.07M12.93M2.57%
Q2 2022
Q2Q % growth
466.9M
4.57%
470.28M-3.38M-0.72%
Q1 2022
Q2Q % growth
461.9M
21.84%
428.42M33.48M7.81%
Q4 2021
Q2Q % growth
415.2M
7.87%
436.17M-20.97M-4.81%
Q3 2021
Q2Q % growth
444.7M
17.00%
429.88M14.82M3.45%
Q2 2021
Q2Q % growth
446.5M
23.34%
386.11M60.39M15.64%
Q1 2021
Q2Q % growth
379.1M
6.40%
376.33M2.77M0.74%
Q4 2020
Q2Q % growth
384.9M
23.72%
369.28M15.62M4.23%
Q3 2020
Q2Q % growth
380.1M
-5.33%
365.63M14.47M3.96%
Q2 2020
Q2Q % growth
362M
-3.10%
346.77M15.23M4.39%
Q1 2020
Q2Q % growth
356.3M
-1.74%
351.21M5.09M1.45%
Q4 2019
Q2Q % growth
311.1M
-18.43%
364.92M-53.82M-14.75%
Q3 2019
Q2Q % growth
401.5M
-2.71%
344.36M57.14M16.59%
Q2 2019
Q2Q % growth
373.6M
-15.95%
338.79M34.81M10.27%
Q1 2019
Q2Q % growth
362.6M
-6.83%
342.14M20.46M5.98%
Q4 2018
Q2Q % growth
381.4M 362.94M18.46M5.09%
Q3 2018
Q2Q % growth
412.7M 388.03M24.67M6.36%
Q2 2018
Q2Q % growth
444.5M 375.95M68.55M18.23%
Q1 2018
Q2Q % growth
389.2M 403.12M-13.92M-3.45%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 13.18% -0.03% -1.05%
Revenue0% 6.62% 0% 1.48%